The Odylia Collective

The Odylia Collective
Odylia is building a centralized marketplace to ensure critical resources are findable and accessible for patient groups and other members of the rare disease research community. Ultimately, centralizing these resources will decrease wasted time and money, and increase the speed at which drugs are developed for rare diseases. Driven by the complexity in connecting the disparate pieces of drug development, The Odylia Collective will connect patient groups and the research community with a growing collection of service providers including: manufacturers, clinical CROs, animal testing, cell line producers, biobanking services, and more.
Help us shape the ecosystem you wish existed today